Who we are
AuriSense is a healthcare technology company developing integrated neuromonitoring systems that translate physiological signals into actionable clinical insight across a range of acute and emergent conditions. By combining a noninvasive sensing device with intelligent software that captures, processes, and interprets neurological and autonomic signaling, AuriSense delivers a unified platform designed to support timely, informed decision-making when conventional diagnostic resources are limited.
The AuriSense platform focuses on converting complex physiological data into clear, interpretable outputs that can assist with assessment, triage, and escalation of care. The system is designed to operate rapidly, function offline, and integrate smoothly into existing clinical workflows, enabling practical use across diverse care settings without adding complexity or burden to frontline teams.
AuriSense is currently advancing its technology through early development and validation in collaboration with clinical and engineering partners. Additional information about the platform and its applications will be shared as development progresses.
Our Team
Jai Thakor, MHS, PMP
Founder & CEO
Daniel Swedien, MD
Clinical Director
David Sherman, PhD
Principal Investigator
Laura Rice, PhD
Regulatory Lead
Medical Advisors
Sung-Min Cho, DO, MHS
Associate Professor, Neurology, Surgery, Anesthesiology & Critical Care, Johns Hopkins University
Raj Mukherjee, MD, MPH
Associate Professor, Neurosurgery, Johns Hopkins University
Eva Ritzl, MD
Professor, Neurology, Weill Cornell Medicine
Henry Brem, MD
Professor, Neurosurgery, Johns Hopkins University
Business Advisors
Abhishek Rege, PhD
CEO, Vasoptic
Steve Weisner
CEO, Nihon Kohden Innovation Center
Rutwik Ghodadra, MBA
CEO, Guidepoint Insights Services